Patents by Inventor Nicolas Philip Van Der Meulen

Nicolas Philip Van Der Meulen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • [161Tb]-BASED RADIOPEPTIDES
    Publication number: 20230293736
    Abstract: A radiopeptide is provided which comprises (a) a radionuclide, wherein the radionuclide is terbium-161, (b) a chelator coordinating terbium-161, and (c) a peptide or peptide analogue, which is a somatostatin receptor (SSTR) antagonist. The radiopeptide is suitable for use in the treatment of tumor diseases.
    Type: Application
    Filed: February 21, 2023
    Publication date: September 21, 2023
    Inventors: Cristina Müller, Roger Schibli, Nicolas Philip Van Der Meulen, Francesca Borgna, Damian Wild, Melpomeni Fani
  • [161Tb]-BASED RADIOPEPTIDES
    Publication number: 20230165981
    Abstract: A radiopeptide is provided which comprises (a) a radionuclide, wherein the radionuclide is terbium-161, (b) a chelator coordinating terbium-161, and (c) a peptide or peptide analogue, which is a somatostatin receptor (SSTR) antagonist. The radiopeptide is suitable for use in the treatment of tumor diseases.
    Type: Application
    Filed: September 29, 2022
    Publication date: June 1, 2023
    Inventors: Cristina Müller, Roger Schibli, Nicolas Philip Van Der Meulen, Francesca Borgna, Damian Wild, Melpomeni Fani